Chronic disease doesn't get solved in a 15-minute appointment. It gets managed through hundreds of small decisions over years. Here's how I approach diabetes, hypertension, and heart disease in my practice, and what actually changes with longer visits and real coordination.

Psychedelic medicine has re-emerged as one of the more interesting areas of psychiatric research. For treatment-resistant depression and end-of-life anxiety, the psilocybin evidence is real. Here's a clinical read on what the science actually shows, how the therapeutic model works, and who should or shouldn't consider it.

GLP-1 agonists (Ozempic, Wegovy, Mounjaro, Zepbound) are the most consequential development in metabolic medicine in over a decade. Here's a clinical view of how they work, where they fit in diabetes, weight, and cardiovascular care, and what the side-effect picture actually looks like.

"Concierge medicine" means wildly different things in different practices. Some charge $800 a year; others charge $25,000. Here's how the three tiers actually work, what each costs, and the questions I'd ask before joining any of them.